Georgios Karagkounis, M.D.Surgery For the first time, an immunotherapy drug has generated a100% remission rate for a specific form of rectal cancer. This promising study of 12 patients, which was led by Memorial Sloan Kettering Cancer Center (MSKCC), made headlines around the world and piqued the interest of cancer patients and casual observers alike. (In […]
The post What does the rectal cancer trial's 100% remission rate mean for young patients? appeared first on Texas Metro News.
